Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epzicom vs Truvada with Boosted Atazanavir in HIV
NCT00544128Phase 4Completed
- Sponsor
- National Center for Global Health and Medicine
- Start
- Oct 2007
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abacavir + lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by National Center for Global Health and Medicine. Started Oct 2007; status: completed.
02
Drugs
abacavir + lamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00544128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544128.